- Home
- QGEN vs CHRD Comparison
QGEN vs CHRD Comparison
Compare QGEN & CHRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QGEN | CHRD |
|---|---|---|
| Founded | 1986 | 2007 |
| Country | Netherlands | United States |
| Employees | N/A | 676 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 8.2B |
| IPO Year | 1998 | N/A |
Fundamental Metrics
Financial Performance| Metric | QGEN | CHRD |
|---|---|---|
| Price | $39.17 | $116.22 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 13 |
| Target Price | $45.76 | ★ $149.17 |
| AVG Volume (30 Days) | ★ 2.2M | 751.6K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 7.17% | 3.56% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.18 | $12.56 |
| Revenue Next Year | $5.71 | N/A |
| P/E Ratio | ★ $24.01 | $34.53 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $32.53 | $84.25 |
| 52 Week High | $57.82 | $151.95 |
Technical Indicators
Market Signals| Indicator | QGEN | CHRD |
|---|---|---|
| Relative Strength Index (RSI) | 63.87 | 29.84 |
| Support Level | $38.80 | $86.73 |
| Resistance Level | $49.27 | $127.56 |
| Average True Range (ATR) | 0.80 | 4.11 |
| MACD | 0.26 | -1.55 |
| Stochastic Oscillator | 90.18 | 3.31 |
Price Performance
Historical ComparisonAbout QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
About CHRD Chord Energy Corporation
Chord Energy Corp is an independent exploration and production (E&P) company engaged in the acquisition, exploration, development and production of crude oil, NGL and natural gas prominently in the Williston Basin, with limited non-operated interests in the Marcellus Shale. It operates in one reportable business segment, which is the E&P of crude oil, NGL and natural gas. The company derives revenue from the sale of crude oil, NGL and natural gas production.